Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alendronate for Asthma
NCT02230332Phase 3Completed
- Sponsor
- Penn State Health Milton S. Hershey Medical Center
- Start
- Jan 2015
- Primary completion
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of alendronate in asthma, sponsored by Penn State Health Milton S. Hershey Medical Center. Started Jan 2015; status: completed.
02
Drugs
alendronate
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02230332.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02230332.